Overnight Low-Oxygen Air Study for Weight in Adults with Obesity
Tests overnight low-oxygen air alongside calorie restriction in adults with obesity.
Key facts
- Who runs it
- Pennington Biomedical Research Center
- Where
- Baton Rouge, United StatesSee the site
- Trial code
- Registry title
- Low Oxygen Exposure and Weight Status
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 16 May 2023
- Expected to end
- 30 Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Normobaric hypoxia (NH)
- Normobaric normoxia (NN)
- Record updated
- 16 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obesity who are willing to sleep 8 hours a night in a home tent for 8 weeks while also eating fewer calories.
- Age
- 22 to 65 years
- Sex
- All sexes can join.
- Disease stage
- Obesity with a BMI between 30 and 39.9 kg/m2.
- Earlier treatment
- No medicine that interferes with oxygen delivery or transport (for example sedatives, sleeping aids, tranquilizers, diuretics, alpha and beta blockers) for 4 weeks before and during the study. A full COVID-19 vaccination series at least 14 days before any in-person research activity.
- Biomarker or test result
- Oxygen saturation of 95% or more while awake. Hematocrit at least 42% for men and 36% for women. Hemoglobin at least 13 g/dL for men and 12 g/dL for women.
Main reasons for not taking part
- Heart or blood vessel disease, stomach or bowel disorders, or any condition that interferes with oxygen delivery, such as kidney disease
- Sleep apnea or other sleeping disorders
- Pregnant, breastfeeding, planning pregnancy, or irregular periods in the past 6 months
- Weight gain or loss of more than 10% of body weight in the past 6 months
- Sickle cell anemia or trait, in the person or the family
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Obese (BMI between 30-39.9 kg/m2)
- Born at altitudes below 2,100 meters (~7,000 feet)
- Currently residing in Tallahassee, Florida or surrounding area
- Completed a full FDA authorized or approved COVID-19 vaccination series at least 14 days before any in-person human research activity
- Not taking any medication(s) that interfere with oxygen delivery/transport for 4 weeks prior to and throughout the entire study (e.g., includes sedatives, sleeping aids, tranquilizers and/or any medication that depresses ventilation, diuretics, alpha and beta blockers)
- Willing to refrain from smoking, vaping, chewing tobacco, and dietary supplement use throughout the entire study
- Willing to have a hypoxic tent set-up in their home and spend 8 consecutive hours per night in the tent for 8 weeks
- Lives with a family member, partner/spouse, or roommate who can hear and respond in the unlikely event that the blood oxygen, air oxygen, or air carbon dioxide monitoring alarm would sound
Who cannot take part
- Individuals who have not completed a full FDA authorized or approved COVID-19 vaccination series at least 14 days before any in-person human research activity
- Evidence of prior high-altitude pulmonary edema (HAPE) or high-altitude cerebral edema (HACE) diagnosis
- Cardiovascular abnormalities, gastrointestinal disorders, or any condition that interferes with oxygen delivery/transport (e.g., kidney disease, cardiovascular disease, etc.)
- Oxygen saturation < 95% while awake or oxygen saturation dips below 88% for a total of ≥ 10 min overnight in normoxic conditions
- Evidence of apnea or other sleeping disorders
- Diagnosis or family history of sickle cell anemia/trait
- Present condition of alcoholism, anabolic steroids, or other substance abuse issues
- Hemoglobin <13 g/dL for males, <12 g/dL for females
- Living in areas that are more than 1,200 m (~4,000 feet), or have traveled to areas that are more than 1,200 m for five days or more within the last 2 months
- Hematocrit <42% for males, <36% for females
- Blood donation within 8 weeks of beginning the study
- Women who are pregnant, lactating, planning to become pregnant, or who have had an irregular menstrual cycle in the past 6 mo
- Weight gain or loss > 10% of body weight during the past 6 months
- Adults unable to consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 22 and 65 years old?
Where in United States
- Pennington Biomedical Research CenterBaton Rouge, United StatesContact: Claire E Berryman, PhD,RDTaking people
About the trial
What the trial wants to find out
The objective of the proposed double-blind, parallel-arm, randomized clinical trial is to evaluate changes in body weight and composition, assess determinants of energy balance (intake and expenditure), and measure modulators of energy balance, following 8 wk of calorie restriction (-500 kcal/d) in combination with either overnight exposure to normobaric hypoxia (8 h/night, 15% FiO2, ~2640 m) or normoxia (8 h/night, 21% FiO2), using a commercially available, in-home tent system, in adults with obesity.
The 2 groups in the trial
- Normobaric hypoxia (NH)Treatment being tested
8 weeks of overnight exposure (8 hrs/night) to NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY).
- Normobaric normoxia (NN)Sham treatment, for comparison
8 weeks of overnight exposure (8 hrs/night) to NN conditions (\~21% oxygen; sea level) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Daily Low Oxygen Exposure on Weight Status, Body Composition, and Metabolic Health
- Plain-language title
- Overnight Low-Oxygen Air Study for Weight in Adults with ObesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05289310, who can take part
- Publications
- Record updated
- 16 July 2026